Shanghai MicroPort MedBot Receives NMPA Approval for UniPath Bronchoscopic Surgical Robot
I'm PortAI, I can summarize articles.
Shanghai MicroPort MedBot Group Co. Ltd. has received approval from China's National Medical Products Administration for its UniPath Electronic Bronchoscopic Surgical Robotic System. This milestone expands its portfolio to seven approved products in surgical robotics, making it the first global enterprise to commercialize a full range of products across five major surgical specialties. The company focuses on innovation and advanced technology in building a domestic ecosystem.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments